CELL & GENE THERAPY INSIGHTS

Spotlight

Viral vector bioprocessing & analytics: tools and innovations to meet future demand

Apr 2020
Guest Editor:
Nolan Sutherland, Scientist, Molecular and Vector Biology at bluebird bio
Nolan Sutherland
Scientist, Molecular and Vector Biology at bluebird bio

Expert Insight

Lentiviral vector manufacturing process enhancement utilizing TFDF technology

Thomas Williams,
Oliver Goodyear,
Lee Davies ,
Carol Knevelman,
Michael Bransby,
Kyriacos Mitrophanous,
James Miskin
5 May 2020
Expert Insight

Innovator Insight


Interview


Report

Innovator Insight

Addressing the current limitations of AAV gene therapies

Dmitry A Kuzmin,
Natalie R Johnston
1 May 2020
Innovator Insight

Interview


Report

Report

Commercial Insights

Cell & Gene Therapy Commercial Insight – February 2020

Mark Curtis,
Richard Philipson
19 March 2020
Commercial Insights

Other articles

Research Article

Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain

Adriana Lopes,
Rob Noel,
Andrew Sinclair
2 June 2020
Research Article

Webinars

Lentiviral vector process to accelerate cell and gene therapy clinical development and commercialization

Lentiviral vector process to accelerate cell and gene therapy clinical development and commercialization

Kevin Beck
Kevin Beck, Senior Account Manager at Lentigen Technology Inc
16 April 2020
Webinar
Scaling up viral vector manufacturing with adherent and suspension cell cultures

Scaling up viral vector manufacturing with adherent and suspension cell cultures

Clive Glover
Clive Glover, Director, Strategy at Pall Biotech
Rachel Legmann
Rachel Legmann, Senior Cell Culture Process Development Manager at Pall Biotech
Siddharth Gupta
Siddharth Gupta, Senior Bioprocess Specialist at Pall Biotech
21 April 2020
Webinar
Advances in gene therapy delivery: next-generation transfection reagent for large-scale AAV manufacturing

Advances in gene therapy delivery: next-generation transfection reagent for large-scale AAV manufacturing

Mathieu Porte
Mathieu Porte, BioProduction R&D Manager, Polyplus-transfection
Malik Hellal
Malik Hellal, Senior Scientist, Chemistry at Polyplus-transfection
29 April 2020
Webinar
Stable AAV producer cell lines: elevating vector manufacturing

Stable AAV producer cell lines: elevating vector manufacturing

Silke Wissing
Silke Wissing, Chief Scientific Officer
5 May 2020
Webinar
AAV downstream processing for industrial scale production – moving towards commercial manufacturing

AAV downstream processing for industrial scale production – moving towards commercial manufacturing

Orjana Terova
Orjana Terova, Senior Product Manager, POROS Chromatography Product Line at Thermo Fisher Scientific
Mikhail Goldfarb
Mikhail Goldfarb, Principal Scientist, Downstream Process Development at Regenxbio, Inc
20 May 2020
Webinar